Home › Funds › PERKINS CAPITAL MANAGEMENT INC › BDSX
PERKINS CAPITAL MANAGEMENT INC position in BDSX
BIODESIX INC · Health Care
PERKINS CAPITAL MANAGEMENT INC reported holding 61,335 shares of BDSX (BIODESIX INC) in its Q3 2026 13F filing — a position valued at US$1.8M, representing 1.31% of its reported portfolio and ranking #23 among its reported holdings. PERKINS CAPITAL MANAGEMENT INC has disclosed BDSX holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How PERKINS CAPITAL MANAGEMENT INC's BDSX position evolved
PERKINS CAPITAL MANAGEMENT INC first disclosed a stake in BDSX in Q2 2024 at 414,782 shares (US$635K). The position peaked in Q3 2026 at 61,335 shares, worth US$1.8M. Across 10 filings, PERKINS CAPITAL MANAGEMENT INC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 61,335 shares valued at US$1.8M — an increase of 16,717 shares quarter over quarter.. Notable position changes include a 75% increase in Q3 2024 (shares fell 14% over the following quarter), a 46% increase in Q4 2024 (shares fell 59% over the following quarter), a 95% trim in Q3 2025 (shares fell 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 414.78K | $635.00K | New |
| Q3 2024 | 724.78K | $1.29M | Add |
| Q4 2024 | 1.06M | $1.62M | Add |
| Q1 2025 | 1.06M | $662.53K | Hold |
| Q2 2025 | 1.06M | $299.05K | Hold |
| Q3 2025 | 52.63K | $397.38K | Reduce |
| Q4 2025 | 44.78K | $304.52K | Reduce |
| Q1 2026 | 44.78K | $649.35K | Hold |
| Q2 2026 | 44.62K | $1.01M | Hold |
| Q3 2026 | 61.34K | $1.83M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BDSX and 13F data
BDSX (BIODESIX INC) is a Health Care company. 41 other funds we track also report a position in BDSX — the largest reported positions include AIGH Capital Management LLC (US$20.5M), Telemark Asset Management, LLC (US$16.1M), ESSEX INVESTMENT MANAGEMENT CO LLC (US$7.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BDSX
- AIGH Capital Management LLC 686.02K sh · $20.46M · Q3 2026
- Telemark Asset Management, LLC 539.82K sh · $16.10M · Q3 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 234.54K sh · $7.00M · Q3 2026
- Birchview Capital, LP 286.80K sh · $6.47M · Q2 2026
- Opaleye Management Inc. 180.00K sh · $4.06M · Q2 2026
More on PERKINS CAPITAL MANAGEMENT INC
FAQ
How long has PERKINS CAPITAL MANAGEMENT INC held BDSX?
PERKINS CAPITAL MANAGEMENT INC has disclosed BDSX holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is PERKINS CAPITAL MANAGEMENT INC's current position in BDSX?
As of Q3 2026, PERKINS CAPITAL MANAGEMENT INC holds 61.34K shares of BDSX (BIODESIX INC), valued at $1.83M, representing 1.31% of its reported portfolio and ranking #23.
Has PERKINS CAPITAL MANAGEMENT INC been buying or selling BDSX?
In the latest 13F filing (Q3 2026), PERKINS CAPITAL MANAGEMENT INC increased its position in BDSX. The position peaked in Q3 2026 at 61.34K shares.
Which other funds hold BDSX?
Other major institutional holders of BDSX include AIGH Capital Management LLC, Telemark Asset Management, LLC, ESSEX INVESTMENT MANAGEMENT CO LLC, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.